Increase control, reduce costs with DissolvIt

  • 5 December, 2013
  • 15:52

DissolvIt – Inhalation Sciences’ in vitro simulation module – has been continuously enhanced over years of close collaboration with, amongst others, Astra Zeneca and GSK. Today it includes…

First buyers and major industry interest for PreciseInhale

  • 20 September, 2013
  • 15:51

PreciseInhale, Inhalation Sciences’ flagship patented precision dosing system for early stage inhalation drug development, is currently earning the attention of a range of respiratory medical companies, inhalation labs…

US Patent Approval for PreciseInhale System

  • 19 September, 2013
  • 15:51

STOCKHOLM – September 18, 2013. Inhalation Sciences Sweden AB, a portfolio company of Karolinska Development, announces today that the company has received US Patent Approval for its flagship…

Please also visit our lab-blog to read more about the latest technical updates from our lab!

Read more

See our Events schedule. Meet an ISAB expert, and explore PreciseInhale for yourself.

Upcoming events